Addiction & Stroke
Recruiting · NCT06187025 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)Ecological Momentary Assessment (EMA)
What this trial is about
Modifiable stroke risk-factors, which include poor lifestyle habits, account for 90 % of the risk of stroke. Disability Adjusted Life Years (DALYs) related to cerebrovascular disorders rely on three main factors, including the severity of stroke-related symptoms, the occurrence of stroke complications, and stroke recurrences. Stroke complications and the risk of stroke recurrence are highly dependent on the control of vascular risk factors. Thus, the secondary prevention of stroke involves profound lifestyle modifications including substance use cessation and diet changes.
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Male or female
- At least 18 years of age and younger than 80 years;
- Recent (≤ 15 days) clinically symptomatic ischemic or hemorrhagic stroke documented through brain imaging (CT or MRI) or a Transient Ischemic Attack with an ABCD2 score ≥ 4;
- Returning to the Bordeaux Hospital neurovascular unit for the standard care 3-months post-stroke follow-up visit;
- National Institute Health Stroke Scale (NIHSS) \< 15;
- modified Rankin scale ≤ 4;
- No severe cognitive impairment as defined by the neurologist;
- Written informed consent by the patient;
- Coverage by the French National Health Insurance.
- For the feasibility study assessing the acceptability of the eHealth device to optimize stroke secondary prevention, additional inclusion criteria will be the ability to use a smartphone and living in an area with internet coverage.
Exclusion criteria
- Subarachnoid hemorrhage; Dementia syndrome or other neurologic disorder;
- Severe aphasia (NIHSS item 9 ≥ 2) and/or Severe visual impairment interfering with the completion of evaluations;
- Severely impaired physical and/or mental health that, according to the neurologist, may affect the participant's capacity to participate in the study;
- Pregnancy or breastfeeding;
- Inability to read French;
- Individuals under legal protection or unable to personally express their consent
- Participation in another protocol modifying the patient's follow-up status
Where it is running
1 location listed.
- CHU de Bordeaux - Bordeaux, France